These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19762335

  • 1. Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3.
    Leeman-Neill RJ, Wheeler SE, Singh SV, Thomas SM, Seethala RR, Neill DB, Panahandeh MC, Hahm ER, Joyce SC, Sen M, Cai Q, Freilino ML, Li C, Johnson DE, Grandis JR.
    Carcinogenesis; 2009 Nov; 30(11):1848-56. PubMed ID: 19762335
    [Abstract] [Full Text] [Related]

  • 2. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors.
    Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR.
    Clin Cancer Res; 2010 May 01; 16(9):2571-9. PubMed ID: 20388852
    [Abstract] [Full Text] [Related]

  • 3. Guggulsterone (GS) inhibits smokeless tobacco and nicotine-induced NF-κB and STAT3 pathways in head and neck cancer cells.
    Macha MA, Matta A, Chauhan SS, Siu KW, Ralhan R.
    Carcinogenesis; 2011 Mar 01; 32(3):368-80. PubMed ID: 21177768
    [Abstract] [Full Text] [Related]

  • 4. Targeting Stat3 abrogates EGFR inhibitor resistance in cancer.
    Sen M, Joyce S, Panahandeh M, Li C, Thomas SM, Maxwell J, Wang L, Gooding WE, Johnson DE, Grandis JR.
    Clin Cancer Res; 2012 Sep 15; 18(18):4986-96. PubMed ID: 22825581
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of EGFR-STAT3 signaling with erlotinib prevents carcinogenesis in a chemically-induced mouse model of oral squamous cell carcinoma.
    Leeman-Neill RJ, Seethala RR, Singh SV, Freilino ML, Bednash JS, Thomas SM, Panahandeh MC, Gooding WE, Joyce SC, Lingen MW, Neill DB, Grandis JR.
    Cancer Prev Res (Phila); 2011 Feb 15; 4(2):230-7. PubMed ID: 21163936
    [Abstract] [Full Text] [Related]

  • 6. MyD88-Dependent Signaling Decreases the Antitumor Efficacy of Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer Cells.
    Koch AT, Love-Homan L, Espinosa-Cotton M, Stanam A, Simons AL.
    Cancer Res; 2015 Apr 15; 75(8):1657-67. PubMed ID: 25712126
    [Abstract] [Full Text] [Related]

  • 7. Bortezomib up-regulates activated signal transducer and activator of transcription-3 and synergizes with inhibitors of signal transducer and activator of transcription-3 to promote head and neck squamous cell carcinoma cell death.
    Li C, Zang Y, Sen M, Leeman-Neill RJ, Man DS, Grandis JR, Johnson DE.
    Mol Cancer Ther; 2009 Aug 15; 8(8):2211-20. PubMed ID: 19638453
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
    Wu K, Mao YY, Chen Q, Zhang B, Zhang S, Wu HJ, Li Y.
    Cell Oncol (Dordr); 2021 Oct 15; 44(5):1167-1181. PubMed ID: 34460078
    [Abstract] [Full Text] [Related]

  • 11. S-Nitrosoglutathione-mediated STAT3 regulation in efficacy of radiotherapy and cisplatin therapy in head and neck squamous cell carcinoma.
    Kaliyaperumal K, Sharma AK, McDonald DG, Dhindsa JS, Yount C, Singh AK, Won JS, Singh I.
    Redox Biol; 2015 Dec 15; 6():41-50. PubMed ID: 26177470
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Hypoxia Mediates Differential Response to Anti-EGFR Therapy in HNSCC Cells.
    Wiechec E, Hansson KT, Alexandersson L, Jönsson JI, Roberg K.
    Int J Mol Sci; 2017 Apr 29; 18(5):. PubMed ID: 28468237
    [Abstract] [Full Text] [Related]

  • 14. 14-3-3 zeta is a molecular target in guggulsterone induced apoptosis in head and neck cancer cells.
    Macha MA, Matta A, Chauhan S, Siu KM, Ralhan R.
    BMC Cancer; 2010 Nov 30; 10():655. PubMed ID: 21118500
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hypoxia induces TFE3 expression in head and neck squamous cell carcinoma.
    Sun ZJ, Yu GT, Huang CF, Bu LL, Liu JF, Ma SR, Zhang WF, Liu B, Zhang L.
    Oncotarget; 2016 Mar 08; 7(10):11651-63. PubMed ID: 26872381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inhibition of STAT-3 results in greater cetuximab sensitivity in head and neck squamous cell carcinoma.
    Bonner JA, Yang ES, Trummell HQ, Nowsheen S, Willey CD, Raisch KP.
    Radiother Oncol; 2011 Jun 08; 99(3):339-43. PubMed ID: 21704410
    [Abstract] [Full Text] [Related]

  • 19. Guggulsterone inhibits angiogenesis by blocking STAT3 and VEGF expression in colon cancer cells.
    Kim ES, Hong SY, Lee HK, Kim SW, An MJ, Kim TI, Lee KR, Kim WH, Cheon JH.
    Oncol Rep; 2008 Dec 08; 20(6):1321-7. PubMed ID: 19020709
    [Abstract] [Full Text] [Related]

  • 20. EPR Oximetry of Cetuximab-Treated Head-and-Neck Tumours in a Mouse Model.
    Gustafsson H, Kale A, Dasu A, Lund A, Edqvist PH, Roberg K.
    Cell Biochem Biophys; 2017 Dec 08; 75(3-4):299-309. PubMed ID: 28756482
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.